Current and future perspectives of liquid biopsies in genomics-driven oncology

Current and future perspectives of liquid biopsies in genomics-driven oncology

Current and future perspectives of liquid biopsies in genomics-driven oncology, Published online: 08 November 2018; doi:10.1038/s41576-018-0071-5

Liquid biopsies enable non-invasive, longitudinal analysis of tumour components (including circulating tumour cells and circulating tumour DNA) in bodily fluids such as blood. However, their analytical and clinical validity must be rigorously demonstrated before they are adopted for precision oncology.

Articles You May Like

Bernese Mars camera CaSSIS returns spectacular images
Materials could delay frost up to 300 times longer than existing anti-icing coatings
Green tea cuts obesity, health risks in mice
Nitrogen pollution’s path to streams weaves through more forests (and faster) than suspected
Danger of vitamin B12 deficiency

Leave a Reply

Your email address will not be published. Required fields are marked *